Effects of phosphodiesterase inhibitors on oesophageal neuromuscular functions

Neurogastroenterology and Motility

Volumn 15, Issue 6, 2003, Pages 625-633

  Park, H ^a   Clark, E ^b   Conklin, J L ^c  

^a Yonsei University College of Medicine   (South Korea)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Adenosine 3 ,5 cyclic monophosphate; Enteric nervous system; Guanosine 3 ,5 cyclic monophosphate; Lower oesophageal sphincter; Oesophagus; Phosphodiesterase

Indexed keywords

CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE; VASOACTIVE INTESTINAL POLYPEPTIDE; ZAPRINAST; ZARDAVERINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; ESOPHAGUS FUNCTION; ESOPHAGUS MUSCLE; FEMALE; LOWER ESOPHAGUS SPHINCTER; MALE; MOTOR ACTIVITY; MUSCLE RELAXATION; MUSCLE TONE; NEUROMUSCULAR FUNCTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE;

ANIMALS; ELECTRIC STIMULATION; ESOPHAGOGASTRIC JUNCTION; ESOPHAGUS; FEMALE; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; OPOSSUMS; PHOSPHODIESTERASE INHIBITORS;

EID: 0347595574     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1350-1925.2003.00444.x     Document Type: Article

References (22)

1. Biancani P, Walsh JH, Behar J. Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest 1984; 73: 963-7.
2. Rattan S, Gray M, Goyal R. Vasoactive intestinal peptide causes peristaltic contractions in the esophageal body. Life Sci 1982; 30: 1157-563.
3. Murray J, Du C, Ledlow A, Bates JN, Conklin JL. Nitric oxide: mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle. Am J Physiol 1991; 261: G401-6.
4. Murray J, Bates JN, Conklin JL. Nerve-mediated nitric oxide production by the opossum lower esophageal sphincter. Dig Dis Sci 1994; 39: 1872-6.
5. Torphy TJ, Fine CF, Burman M, Barnette MS, Ormsbee HS. Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content. Am J Physiol 1986; 251: G786-93.
6. Murray J, Du C, Ledlow A., Maternach RL, Conklin JL. Guanylate cyclase inhibitors: effect on tone, relaxation, and cGMP content of lower esophageal sphincter. Am J Physiol 1992; 263: G97-G101.
7. Barnette MS, Barone FC, Fowler PJ, Grous M, Price WJ, Ormsbee HS. Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content. Gut 1991; 32: 4-9.
8. Beavo JA, Conti M, Heaslip RJ. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 1994; 46: 399-405.
9. Burns F, Zhao AZ, Beavo JA. Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation and physiological implications. Adv Pharmacol 1996; 36: 29-48.
10. Nicholson CD, Challiss RAJ, Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 1991; 12: 19-27.
11. Barnette M, Torphy TJ, Grous M, Fine C, Ormsbee HS. Cyclic GMP: a potential mediator of neurally and drug-induced relaxation of the opossum lower esophageal sphincter. J Pharm Exp Ther 1989; 249: 524-8.
12. Osinski MA, Bass P, Gaumnitz EA. Effects of selective phosphodiesterase inhibitors on the opossum lower esophageal sphincter. Gastroenterology 1998; 114: A816.
13. Murray J, Shibata EF, Buresh TL, Picken H, O'Meara BW, Conklin JL. Nitric oxide modulates a calcium-activated potassium current in muscle cells from the opossum esophagus. Am J Physiol 1995; 32: G606-12.
14. Shahin W, Murray JA, Clark E, Conklin JL. The role of cGMP as a mediator of nerve-induced motor functions of the opossum esophagus. Am J Physiol 2000; 279: G567-74.
15. Uc A, Oh ST, Murray JA, Clark E, Conklin JL. Biphasic relaxation of the lower esophageal sphincter: roles of NO, VIP and CGRP. Am J Physiol 1999; 277: G548-54.
16. Eherer AJ, Schwetz I, Hammer HF et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50: 758-64.
17. Rhee PL, Hyun JG, Lee JH et al. The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults. Am J Gastroenterol 2001; 96: 3251-7.
18. Zhang X, Tack J, Janssens J, Sifrim DA. Effect of sildenafil, a phosphodiesterase-5 inhibitor, on oesophageal peristalsis and lower oesophageal sphincter function in cats. Neurogastroenterol Motil 2001; 13: 325-31.
19. Jung I, Park H, Kim JH, Lee SI, Conklin JL. The effect of sildenafil on esophageal motor function in healthy subjects and nutcracker esophagus. Neurogastroenterol Motil 12: 617-23.
20. Jury J, Daniel EE. Activation of outward K+ currents: effect of VIP in oesophagus. Br J Pharmacol 1999; 127: 553-61.
21. Rao SS, Mudipalli RS, Mujica V, Utech CL, Zao X, Conklin JL. An open trial of theophylline for functional chest pain. Dig Dis Sci 2002; 47: 2763-8.
22. Rattan S, Moummi C. Influence of stimulators and inhibitors of cyclic nucleotides on the lower esophageal sphincter. J Pharmacol Exp Ther 1989; 248: 703-9.